FDC
Back to Balance Sheet
|
FDC Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹23 Cr | ₹17 Cr | ₹11 Cr | ₹16 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FDC ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of FDC Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | 32.90 | |
| Mar2024 | ₹17 Cr | 55.45 | |
| Mar2023 | ₹11 Cr | -31.06 | |
| Mar2022 | ₹16 Cr | 47.83 | |
| Mar2021 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,026.9 Cr | -8.2% | -14.3% | -22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -8.2% |
-14.3% |
-22.6% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses